Quest Diagnostics (DGX) Cash from Operations (2009 - 2026)

Quest Diagnostics has disclosed Cash from Operations across 18 years of filings, most recently posting $597.0 million for Q2 2026.

• In Q2 2026, Cash from Operations rose 9.74% year-over-year to $597.0 million; the TTM figure through Jun 2026 stood at $1.9 billion (up 13.41% YoY), while the FY2025 annual figure was $1.9 billion, up 41.38% from the prior year.
• Cash from Operations came in at $597.0 million for Q2 2026 at Quest Diagnostics, up from $278.0 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $597.0 million in Q2 2026 to a low of $94.0 million in Q1 2023.
• Average Cash from Operations over 5 years is $393.6 million, with a median of $423.0 million recorded in 2022.
• Year-over-year, Cash from Operations plunged 80.42% in 2023 and surged 103.9% in 2025.
• Over 5 years, Cash from Operations stood at $334.0 million in 2022, then soared by 57.78% to $527.0 million in 2023, then decreased by 11.95% to $464.0 million in 2024, then gained by 0.22% to $465.0 million in 2025, then gained by 28.39% to $597.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were $597.0 million in Q2 2026, $278.0 million in Q1 2026, and $465.0 million in Q4 2025.